Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dynamic Assessment of Exercise Gas Exchange Efficiency by Breath-by-Breath Volumetric Capnography in Mild-Moderate COPD.

COPD·2026

Same author

Evaluating the feasibility and preliminary effects of a group-based telerehabilitation program in individuals with persistent dyspnea after COVID-19 (TEPCO): a pilot randomized controlled study.

Pilot and feasibility studies·2026

Same author

Poor Sleep Quality and Heightened Perceptual Responses to Exercise in Community Dwellers: Results from the CanCOLD Study.

Annals of the American Thoracic Society·2026

Same author

Postural relief of dyspnoea is associated with improved neuromechanical coupling in patients with advanced COPD.

The European respiratory journal·2026

Same author

The role of the pulmonary function laboratory in risk assessment for lung resection.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2026

Same author

The role of the pulmonary function laboratory in the assessment of adults with neuromuscular disease.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2026

Search research articles

Related Experiment Video

Updated: Apr 14, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease.

Philippe Gagnon¹, Richard Casaburi², Didier Saey¹

¹Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Québec, Canada.

|April 24, 2015

Summary

Heterogeneity exists within Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1 spirometric category. Three distinct subgroups of GOLD 1 COPD patients were identified, suggesting personalized treatment approaches.

More Related Videos

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

Related Experiment Videos

Last Updated: Apr 14, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

Area of Science:

Pulmonary Medicine
Respiratory Research
Clinical Trials

Background:

Chronic Obstructive Pulmonary Disease (COPD) is a significant global health issue.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification system categorizes COPD severity.
GOLD 1 represents the mildest spirometric stage, but its internal heterogeneity is not well understood.

Purpose of the Study:

To investigate the heterogeneity within the GOLD 1 spirometric category of COPD.
To identify distinct subgroups of patients within the GOLD 1 COPD classification.
To determine if these subgroups differ in clinical characteristics and daily activity levels.

Main Methods:

Utilized pre-randomization data from two clinical trials involving GOLD 1 COPD patients and healthy controls.
Employed hierarchical cluster analysis based on demographics, symptoms, lung function, exercise capacity, and physical activity.
Compared characteristics of identified clusters to healthy controls and between COPD subgroups.

Main Results:

Significant clinical heterogeneity was observed among GOLD 1 COPD patients.
Three distinct clusters emerged: Cluster I (predominantly controls), Cluster II (mostly COPD patients with higher smoking history and hyperinflation), and Cluster III (COPD patients with reduced physical activity and lower FEV1/FVC).
Cluster I COPD patients showed preserved lung volumes and exercise capacity, differing from controls mainly in diffusion capacity and baseline dyspnea.

Conclusions:

The findings confirm substantial heterogeneity within the GOLD 1 COPD classification.
Subgroup identification supports the need for individualized therapeutic strategies in GOLD 1 COPD management.
Further research into these distinct subgroups may refine COPD treatment paradigms.